| scholarly article | Q13442814 |
| P50 | author | Dong K Ahn | Q92520627 |
| P2093 | author name string | Yong C Bae | |
| Jin S Ju | |||
| Ah R Lee | |||
| Geun W Lee | |||
| Jo Y Son | |||
| P2860 | cites work | Sex differences in pain: a brief review of clinical and experimental findings | Q26823421 |
| The blood-brain barrier/neurovascular unit in health and disease | Q29616335 | ||
| The blood-brain barrier in health and chronic neurodegenerative disorders | Q29616411 | ||
| Angiogenesis as a therapeutic target | Q29619525 | ||
| Astroglia in medullary dorsal horn (trigeminal spinal subnucleus caudalis) are involved in trigeminal neuropathic pain mechanisms | Q33582175 | ||
| Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice | Q33867506 | ||
| Gender differences in pain | Q34154337 | ||
| A high-content biosensor-based screen identifies cell-permeable activators and inhibitors of EGFR function: implications in drug discovery | Q34264284 | ||
| Vascular endothelial growth factor receptor 1 contributes to Escherichia coli K1 invasion of human brain microvascular endothelial cells through the phosphatidylinositol 3-kinase/Akt signaling pathway | Q34290785 | ||
| Pharmacologic management of neuropathic pain: evidence-based recommendations | Q34699259 | ||
| Molecular mechanisms of lymphangiogenesis in health and disease | Q34710547 | ||
| Intracisternal administration of NR2 subunit antagonists attenuates the nociceptive behavior and p-p38 MAPK expression produced by compression of the trigeminal nerve root | Q35069330 | ||
| Behavioral evidence for the differential regulation of p-p38 MAPK and p-NF-κB in rats with trigeminal neuropathic pain. | Q35189130 | ||
| Altered sensation following mandibular implant surgery: a retrospective study | Q35391922 | ||
| Antinociceptive Effects of Transcytosed Botulinum Neurotoxin Type A on Trigeminal Nociception in Rats | Q35843970 | ||
| Progesterone produces antinociceptive and neuroprotective effects in rats with microinjected lysophosphatidic acid in the trigeminal nerve root | Q35860900 | ||
| Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease | Q36068294 | ||
| Hypertonic saline alleviates experimentally induced cerebral oedema through suppression of vascular endothelial growth factor and its receptor VEGFR2 expression in astrocytes | Q36161763 | ||
| Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis | Q36335555 | ||
| Trigeminal nerve injuries after mandibular implant placement--practical knowledge for clinicians. | Q36414718 | ||
| Transition to persistent orofacial pain after nerve injury involves supraspinal serotonin mechanisms | Q36807025 | ||
| Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway | Q36915045 | ||
| Vascular endothelial growth factor mediates corneal nerve repair | Q37051762 | ||
| VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown | Q37100939 | ||
| Role and therapeutic potential of VEGF in the nervous system | Q37431132 | ||
| Inferior alveolar nerve injury in implant dentistry: diagnosis, causes, prevention, and management | Q37764864 | ||
| VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration | Q38087877 | ||
| Blood-nerve barrier dysfunction contributes to the generation of neuropathic pain and allows targeting of injured nerves for pain relief. | Q39212242 | ||
| VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X₂(/)₃ receptor of primary sensory neurons. | Q39281445 | ||
| Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway | Q40169031 | ||
| Pain Management for Nerve Injury following Dental Implant Surgery at Tokyo Dental College Hospital | Q41926209 | ||
| Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats | Q43295901 | ||
| ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. | Q44106085 | ||
| Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. | Q44306964 | ||
| Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury | Q44554982 | ||
| Convergence of cutaneous, tooth pulp, visceral, neck and muscle afferents onto nociceptive and non-nociceptive neurones in trigeminal subnucleus caudalis (medullary dorsal horn) and its implications for referred pain | Q45240605 | ||
| Compression of the trigeminal ganglion produces prolonged nociceptive behavior in rats. | Q45899069 | ||
| The glial-neuronal GRK2 pathway participates in the development of trigeminal neuropathic pain in rats | Q46868828 | ||
| Antinociceptive Effects of Botulinum Toxin Type A on Trigeminal Neuropathic Pain | Q47408714 | ||
| Blood-spinal cord barrier breakdown and pericyte deficiency in peripheral neuropathy | Q48017174 | ||
| A novel trigeminal neuropathic pain model: compression of the trigeminal nerve root produces prolonged nociception in rats | Q48175252 | ||
| Blockade of microglial activation reduces mechanical allodynia in rats with compression of the trigeminal ganglion | Q48220251 | ||
| Chronic catheterization of the spinal subarachnoid space | Q48344815 | ||
| Early dexamethasone relieves trigeminal neuropathic pain | Q48348412 | ||
| Intracisternal administration of COX inhibitors attenuates mechanical allodynia following compression of the trigeminal ganglion in rats | Q48445979 | ||
| Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats | Q48465059 | ||
| Effects of anti-rVEGF on the expression of VEGF receptor-2 and P2X(2/3) receptors of the spinal dorsal horn in neuropathic pain rats. | Q48759166 | ||
| Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. | Q51978147 | ||
| The incidence of altered sensation of the mental nerve after mandibular implant placement. | Q51979293 | ||
| Diabetes mellitus influences the expression of NPY and VEGF in neurons of rat trigeminal ganglion. | Q52964678 | ||
| Vascular endothelial growth factor signaling in injured nerves underlies peripheral sensitization in neuropathic pain. | Q54012562 | ||
| Differential regulation of peripheral IL-1β-induced mechanical allodynia and thermal hyperalgesia in rats. | Q54385530 | ||
| JMJD6 exerts function in neuropathic pain by regulating NF‑κB following peripheral nerve injury in rats | Q59349675 | ||
| Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration | Q73072483 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 1744806919872602 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Molecular Pain | Q15766244 |
| P1476 | title | Central VEGF-A pathway plays a key role in the development of trigeminal neuropathic pain in rats | |
| P478 | volume | 15 |
Search more.